Promising data have emerged suggesting a significant weight loss benefit for patients using GLP-1 agonists and GLP-1/GIP dual agonists.
Ryan Fernholz, PharmD Candidate
Advertisement
Articles by Ryan Fernholz, PharmD Candidate
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Announces Recall 580,000 Bottles of Prazosin Over Potential Carcinogenic Impurity
2
Regular Melatonin Supplementation May Hide Hidden Heart Complications
3
CDC Adolescents, Children, & Adult Immunization Schedule: 2025 Update
4
Tick-Borne Encephalitis Among Travelers to Europe Highlights Need for Expanded Vaccination Efforts
5
